Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0001495
UniProt IDQ9NSA2
Primary gene name(s)KCND1
Synonym gene name(s)unknown
Protein namePotassium voltage-gated channel subfamily D member 1
Protein functionPore-forming, alpha subunit of voltage-gated rapidly inactivating A-type potassium channels. May contribute to I(To current in heart and I(Sa current in neurons. Channel properties are modulated by interactions with other alpha subunits and with regulatory subunits.
Subcellular locationMembrane;
Multi-pass membrane protein. Cell projection, dendrite {ECO:0000250}.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: Q9NSA2
Gene Ontology
(Biological Process)
Complete annatation
cardiac conduction [GO:0061337];
protein homooligomerization [GO:0051260]
Gene Ontology
(Molecular Function)
Complete annatation
A-type, transient outward potassium channel activity [GO:0005250];
metal ion binding [GO:0046872]
Gene Ontology
(Cellular Component)
Complete annatation
dendrite [GO:0030425];
integral component of membrane [GO:0016021];
neuronal cell body [GO:0043025];
plasma membrane [GO:0005886];
voltage-gated potassium channel complex [GO:0008076]
Protein-protein interactionunknown
Phylogenetic treeQ9NSA2
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
Brass et al., Science, 2008
Smith et al., J. Immunol, 2010
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model

DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD30.1868125840624450.5919712506851750.697918545864123
AZA vs. DISU1.54722357328741.42095155227784e-050.0036304107964468
AZA vs. IL7-0.2709908710720620.2471171901348750.99678318522546
AZA vs. SAHA1.00656805121480.0001928383430265250.00613693882113882
DISU vs. CD31.341499226154680.0008978402486038430.00377518658506397
DISU vs. IL7-1.824589341128743.96774545996514e-076.16636729989428e-05
DISU vs. SAHA-0.5344313900289580.1885493061553740.555873746687723
DMSO vs. AZA0.01403325723698560.9472089642010231
DMSO vs. CD3-0.1896982416017240.5775853991417840.676882461149045
DMSO vs. DISU-1.536953266516661.93946252560195e-050.00417538575154592
DMSO vs. IL7-0.2747956676895970.2121999785080020.722422879638603
DMSO vs. SAHA0.9894408581342510.0001485615699865490.00466452379430685
HIV vs. Mock in Activation-0.05982700599933230.9267796710588860.999983755607037
HIV vs. Mock in Latency-0.2285237746443840.2190623593832950.999834320637052
IL7 vs. CD3-0.4545096730509210.1864796476239560.305888315228632
SAHA vs. CD30.796511836704740.03039443040700630.065537854662124
SAHA vs. IL71.278918416593552.39474487317981e-069.60063410061502e-05
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) TRUE
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK 0.167369 0.482277
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
unknown unknown unknown unknown unknown
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

Drugbank ID Drug Name Drug Status Pharmacological Action Drug Action
DB06637 Dalfampridine approved yes antagonist

Protein Secondary Structure       (annotations from PDB)      top

not found

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

not found

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
not found